NICE releases draft guidance on constipation in women

NICE has published draft guidance recommending prucalopride (Resolor, Movetis) as an option for the treatment of chronic constipation in women.

However, NICE has provisionally ruled that prucalopride should only be considered for women who have tried at least two different types of laxative and lifestyle changes for at least six months, but have not had relief from constipation.

A consultation on the guidance will close on 24 August with the final guidelines expected to be published in December.

Have your say

You must sign in to make a comment.

Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.

Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.

Click here to find out more

Related Jobs

Sign in to see the latest jobs relevant to you!